Back to today’s briefing

Story perspectives

CRISPR Breakthrough Restores Muscle Function in LGMD2B

1/7/2025

26 2

Summary

Story summary

A groundbreaking CRISPR-Cas9 gene correction strategy, spearheaded by Simone Spuler, targets a harmful mutation in the DYSF gene linked to limb-girdle muscular dystrophy 2B (LGMD2B). With over 60% correction efficiency, this innovative approach successfully restored functional dysferlin in muscle stem cells and a new mouse model, igniting hope for future treatments.

1 of 1

Story summary

A groundbreaking CRISPR-Cas9 gene correction strategy, spearheaded by Simone Spuler, targets a harmful mutation in the DYSF gene linked to limb-girdle muscular dystrophy 2B (LGMD2B). With over 60% correction efficiency, this innovative approach successfully restored functional dysferlin in muscle stem cells and a new mouse model, igniting hope for future treatments.